EGFR and melanoma: For example, in select cases where patients have small asymptomatic brain metastases from melanoma or ALK rearrangement-positive NSCLC or EGFR-mutated NSCLC, it is reasonable to hold on treating with radiation to see if systemic therapy can control the brain metastases assuming close symptom and imaging surveillance.